Development of Follistatin as Novel Cancer Therapeutic [ 2017 - 2019 ]

Research Grant

Researchers: Prof David Watkins (Principal investigator) ,  A/Pr Vinod Ganju ,  Prof David De Kretser

Brief description In this project, we aim to rapidly commercialise our discovery that Follistatin, an endogenous hormone, can dramatically improve the efficacy of platinum-based chemotherapy in lung cancer.

Funding Amount $AUD 505,898.76

Funding Scheme Development Grants

Notes Development Grant